Cargando…

Prophylactic Anticoagulation in Nephrotic Syndrome

Detalles Bibliográficos
Autores principales:	Gerstein, Jonathon, Battu, Kiran, Reich, Heather N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Nephrology 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617801/ https://www.ncbi.nlm.nih.gov/pubmed/37526679 http://dx.doi.org/10.34067/KID.0000000000000225

Ejemplares similares

Apixaban Prophylactic Anticoagulation in Patients with Nephrotic Syndrome
por: Van Meerhaeghe, Tess, et al.
Publicado: (2022)

Prophylactic anticoagulation in nephrotic syndrome prevents thromboembolic complications
por: Kelddal, Sarah, et al.
Publicado: (2019)

A Systematic Review of Prophylactic Anticoagulation in Nephrotic Syndrome
por: Lin, Raymond, et al.
Publicado: (2019)

Retroperitoneal Bleeding: An Experience During Prophylactic Anticoagulation in a Patient With Nephrotic Syndrome
por: Okada, Mari, et al.
Publicado: (2017)

Longitudinal Analysis of Prophylactic Anticoagulation in Primary Nephrotic Syndrome: Low Incidence of Thromboembolic Complications
por: McDonnell, Thomas, et al.
Publicado: (2023)

Prophylactic anticoagulants to prevent venous thromboembolism in patients with nephrotic syndrome—A retrospective observational study
por: Welander, Frida, et al.
Publicado: (2021)

Progress of research on dyslipidemia accompanied by nephrotic syndrome
por: Tao, Min, et al.
Publicado: (2020)

Direct-Acting Oral Anticoagulants as Prophylaxis Against Thromboembolism in the Nephrotic Syndrome
por: Sexton, Donal J., et al.
Publicado: (2018)

Therapeutic potential of prophylactic exercise for intracerebral hemorrhage
por: Kinoshita, Keita, et al.
Publicado: (2021)

Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology
por: Hampson, Ian N.
Publicado: (2022)

Pneumococcal hemolytic uremic syndrome and steroid resistant nephrotic syndrome
por: Groves, Andrew P., et al.
Publicado: (2016)

Comparison of the prophylactic antithrombotic effect of indobufen and warfarin in patients with nephrotic syndrome: a randomized controlled trial
por: Gao, Xin-Yi, et al.
Publicado: (2023)

COVID-19 and its implications for thrombosis and anticoagulation
por: Connors, Jean M., et al.
Publicado: (2020)

Prophylactic anticoagulation for patients in hospital with covid-19
Publicado: (2021)

Applications and future of aptamers that achieve rapid-onset anticoagulation
por: Yu, Haixiang, et al.
Publicado: (2023)

Safety and effectiveness of direct oral anticoagulants in patients with nephrotic syndrome: a report of 21 cases
por: Kelddal, Sarah, et al.
Publicado: (2022)

Advances of mRNA vaccines for COVID-19: A new prophylactic revolution begins
por: Weng, Yuhua, et al.
Publicado: (2021)

Timing of anticoagulation for the management of portal vein thrombosis in liver cirrhosis
por: Valeriani, Emanuele, et al.
Publicado: (2023)

Direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism
por: Yhim, Ho-Young, et al.
Publicado: (2014)

Pharmacogenetics in the Management of Coumarin Anticoagulant Therapy: The Way Forward or an Expensive Diversion?
por: Greaves, Mike
Publicado: (2005)

Direct oral anticoagulants: a new therapy against Alzheimer’s disease?
por: Grossmann, Klaus
Publicado: (2021)

Anticoagulation in elderly patients at high risk of atrial fibrillation without documented arrhythmias
por: Martínez-Sellés, Manuel, et al.
Publicado: (2017)

Embolic stroke of undetermined source: identification of patient subgroups for oral anticoagulation treatment
por: Greeve, Isabell, et al.
Publicado: (2021)

Nephrotic syndrome associated with meningioma
por: Zachariah, P. P., et al.
Publicado: (2013)

Congenital nephrotic syndrome
por: Jalanko, Hannu
Publicado: (2007)

Complications of nephrotic syndrome
por: Park, Se Jin, et al.
Publicado: (2011)

Studies in the Nephrotic Syndrome
por: Lyon, D. M., et al.
Publicado: (1935)

Prophylactic versus therapeutic anticoagulation for survival of patients with COVID-19 on steroid
por: Kuno, Toshiki, et al.
Publicado: (2021)

Therapeutic Dilemmas Regarding Anticoagulation: An Experience in a Patient with Nephrotic Syndrome, Pulmonary Embolism, and Traumatic Brain Injury
por: Akimoto, Tetsu, et al.
Publicado: (2016)

High-Dose Prophylactic Anticoagulation in Severe COVID-19 Pneumonia
por: Nadeem, Rashid, et al.
Publicado: (2021)

Extracorporeal Therapy for Idiopathic Nephrotic Syndrome
por: Au, Eric, et al.
Publicado: (2021)

Acute Brachial Arterial Embolic Occlusion Following Anticoagulant Discontinuation in a Renal Biopsy of a Nephrotic Syndrome Patient
por: Taniguchi, Tomoki, et al.
Publicado: (2021)

Ponticelli regimen in idiopathic nephrotic syndrome
por: Das, U., et al.
Publicado: (2009)

Diagnosis and Treatment of Patients With Focal Segmental Glomerulosclerosis/Steroid-Resistant Nephrotic Syndrome: A Delphi Survey
por: Floege, Jürgen, et al.
Publicado: (2022)

Are Patients with Active Cancer and Those with History of Cancer Carrying the Same Risks of Recurrent VTE and Bleeding While on Anticoagulants?
por: Frere, Corinne, et al.
Publicado: (2020)

Urinary indices in nephrotic syndrome
por: Sahay, M.
Publicado: (2011)

Ponticelli regimen and nephrotic syndrome
por: Laxminarayana, S.
Publicado: (2009)

Foamy urine in nephrotic syndrome
por: Dantas, Márcio, et al.
Publicado: (2013)

An unusual case of nephrotic syndrome
por: Sahay, M., et al.
Publicado: (2016)

Diabetes and nephrotic syndrome: Questions
por: Gilbert, Rodney D, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_r6u6m9j8vu8tbcisok8tjuafdf